ES2491340B1 - New composition of chitosan conjugates or derivatives with thiolactones - Google Patents

New composition of chitosan conjugates or derivatives with thiolactones Download PDF

Info

Publication number
ES2491340B1
ES2491340B1 ES201300228A ES201300228A ES2491340B1 ES 2491340 B1 ES2491340 B1 ES 2491340B1 ES 201300228 A ES201300228 A ES 201300228A ES 201300228 A ES201300228 A ES 201300228A ES 2491340 B1 ES2491340 B1 ES 2491340B1
Authority
ES
Spain
Prior art keywords
thiolactones
derivatives
conjugates
properties
new composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES201300228A
Other languages
Spanish (es)
Other versions
ES2491340A1 (en
Inventor
María Violante DE PAZ BÁÑEZ
María Rosa JIMÉNEZ-CASTELLANOS BALLESTEROS
María Jesús LUCERO MUÑOZ
Marta CASAS DELGADO
Cristina FERRIS VILLANUEVA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Sevilla
Original Assignee
Universidad de Sevilla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Sevilla filed Critical Universidad de Sevilla
Priority to ES201300228A priority Critical patent/ES2491340B1/en
Publication of ES2491340A1 publication Critical patent/ES2491340A1/en
Application granted granted Critical
Publication of ES2491340B1 publication Critical patent/ES2491340B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/722Chitin, chitosan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/736Chitin; Chitosan; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a conjugados del chitosan (o sus derivados) con tiolactonas (síntesis y estructuras químicas), en las composiciones cosméticas, biomédicas-farmacéuticas que contienen dichos conjugados, y a sus aplicaciones, que presentan las siguientes propiedades: no tóxicos, biodegradables, con excelentes propiedades de mucoadhesión, cohesión e inhibición enzimática, con propiedades mejoradas de permeabilidad, captación celular y gran estabilidad como agentes de recubrimiento de cánulas y otros dispositivos médicos y como sistemas transportadores de fármacos, esto es, con largos tiempos de permanencia de los principios activos englobados, lo que garantiza un excelente control en la liberación de los fármacos incluidos en la formulación y además, capaces de gelificar en presencia de oxígeno.The present invention relates to chitosan conjugates (or their derivatives) with thiolactones (synthesis and chemical structures), in cosmetic, biomedical-pharmaceutical compositions containing said conjugates, and to their applications, which have the following properties: non-toxic, biodegradable , with excellent properties of mucoadhesion, cohesion and enzymatic inhibition, with improved properties of permeability, cellular uptake and great stability as coating agents for cannulas and other medical devices and as drug transport systems, that is, with long residence times of the active ingredients included, which guarantees excellent control in the release of the drugs included in the formulation and also capable of gelling in the presence of oxygen.

Description

imagen1image 1

imagen2image2

imagen3image3

imagen4image4

imagen5image5

imagen6image6

imagen7image7

imagen8image8

imagen9image9

imagen10image10

imagen11image11

imagen12image12

imagen13image13

imagen14image14

imagen15image15

imagen16image16

imagen17image17

imagen18image18

imagen19image19

imagen20image20

imagen21image21

imagen22image22

imagen23image23

imagen24image24

imagen25image25

imagen26image26

imagen27image27

imagen28image28

imagen29image29

imagen30image30

imagen31image31

imagen32image32

imagen33image33

imagen34image34

imagen35image35

imagen36image36

imagen37image37

imagen38image38

imagen39image39

imagen40image40

imagen41image41

imagen42image42

imagen43image43

imagen44image44

imagen45image45

imagen46image46

imagen47image47

imagen48image48

imagen49image49

imagen50image50

imagen51image51

imagen52image52

imagen53image53

imagen54image54

imagen55image55

imagen56image56

imagen57image57

imagen58image58

imagen59image59

imagen60image60

imagen61image61

imagen62image62

imagen63image63

imagen64image64

imagen65image65

imagen66image66

imagen67image67

Claims (1)

imagen1image 1 imagen2image2 imagen3image3 imagen4image4
ES201300228A 2013-03-05 2013-03-05 New composition of chitosan conjugates or derivatives with thiolactones Active ES2491340B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201300228A ES2491340B1 (en) 2013-03-05 2013-03-05 New composition of chitosan conjugates or derivatives with thiolactones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201300228A ES2491340B1 (en) 2013-03-05 2013-03-05 New composition of chitosan conjugates or derivatives with thiolactones

Publications (2)

Publication Number Publication Date
ES2491340A1 ES2491340A1 (en) 2014-09-05
ES2491340B1 true ES2491340B1 (en) 2015-03-31

Family

ID=51452824

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201300228A Active ES2491340B1 (en) 2013-03-05 2013-03-05 New composition of chitosan conjugates or derivatives with thiolactones

Country Status (1)

Country Link
ES (1) ES2491340B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10618986B2 (en) 2016-10-19 2020-04-14 Alcon Inc. Hydrophilic copolymer with pendant thiol groups

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110217084B (en) * 2019-06-28 2024-03-26 佛山科学技术学院 Automobile protection fence

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATA13842001A (en) * 2001-08-31 2002-10-15 Mucobiomer Biotechnologische F CHITOSAN-THIO-ALKYL-AMIDINE CONJUGATES AND THEIR COSMETIC AND PHARMACEUTICAL USE

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10618986B2 (en) 2016-10-19 2020-04-14 Alcon Inc. Hydrophilic copolymer with pendant thiol groups

Also Published As

Publication number Publication date
ES2491340A1 (en) 2014-09-05

Similar Documents

Publication Publication Date Title
SV2017005461A (en) BENZAMIDS REPLACED WITH 1,3-TIAZOL-2-ILO
CL2018002920A1 (en) New pyrazolopyrimidine derivatives
TR201904455T4 (en) 1,2,4-triazoles and their uses as nuclear transport modulators.
EA201591003A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
UY31673A1 (en) "UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME-211"
EA201591004A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
BR112016006209A2 (en) thermoplastic polymer composition
UY35485A (en) HETEROCYCLIC COMPOUNDS AND USES OF THE SAME
CL2015003357A1 (en) 4'-Fluoro-2'-methyl substituted nucleoside derivatives
CR20120255A (en) PURINE OR DEAZAPURINE DERIVATIVES USED FOR THE TREATMENT OF INTER ALIA VIRAL INFECTIONS
CU20190101A7 (en) SUBSTITUTED DIAZABICYCLIC IMIDAZOPYRIMIDINES
PE20150129A1 (en) DELAYED RELEASE DRUG FORMULATION
BR112014022214A2 (en) antibacterial phenolics
DOP2015000170A (en) CHEMICAL COMPOUNDS
DOP2019000275A (en) NEW BICYCLIC PIRAZOLE DERIVATIVES
BR112015031329A2 (en) compositions comprising cyclodextrin and cross-linked hyaluronic acid
CU20200008A7 (en) SUBSTITUTE DIHYDROOXADIAZINONE COMPOUNDS USEFUL IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES, METHODS FOR PREPARING SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UY37250A (en) INDOL MACROCYCLIC DERIVATIVES
DOP2016000007A (en) SUBSTITUTED PIRAZOLPIRIDINS
BR112017000246A2 (en) compound, pharmaceutically acceptable salt of a compound, pharmaceutical composition, and use of a compound or salt
CL2017001025A1 (en) Compounds for use in anthelmintic treatment
CL2017002451A1 (en) Novel heterocyclic compounds and their use in the prevention or treatment of bacterial infections
BR112014030720A8 (en) compound, pharmaceutical composition and uses of fbx03 inhibitors
CO7131368A2 (en) (r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) -nifuratel
CL2017002803A1 (en) Heterocyclic compounds and their use in the prevention or treatment of bacterial infections

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2491340

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20150331